PTEN公司
PI3K/AKT/mTOR通路
前列腺癌
BETA（编程语言）
癌症研究
化学
计算生物学
癌症
药理学
医学
生物
细胞凋亡
内科学
生物化学
计算机科学
程序设计语言
作者
Hong Lin,Mark J. Schulz,Ren Xie,Jin Zhang,Juan I. Luengo,Michael D. Squire,Rosanna Tedesco,Junya Qu,Karl F. Erhard,James F. Mack,Kaushik Raha,Ramona Plant,Cynthia M. Rominger,Jennifer L. Ariazi,Christian Sherk,Michael D. Schaber,Jeanelle McSurdy-Freed,Michael D. Spengler,Charles B. Davis,Mary Ann Hardwicke,Ralph A. Rivero
摘要
A novel thiazolopyrimidinone series of PI3K-beta selective inhibitors has been identified. This chemotype has provided an excellent tool compound, 18, that showed potent growth inhibition in the PTEN-deficient breast cancer cell line MDA-MB-468 under anchorage-independent conditions, and it also demonstrated pharmacodynamic effects and efficacy in a PTEN-deficient prostate cancer PC-3 xenograft mouse model.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
BowieHuang
无极微光
ceeray23
pluto
Criminology34
niNe3YUE
Dali
LYW
Stella
子车茗
Zx_1993
djshao
不倦
李李李
黑猫乾杯
夜琉璃
freyaaaaa
tuanheqi
积极从蕾
luis
蓝天
优美紫槐
Dean
ZOE
皖公网安备34019202002308
